Y. Ueda

发表

Basic Studies Toward Hematopoietic Stem Cell Gene Therapy

K. Ozawa, K. Terao, Y. Hanazono, 2000 .

Long-term tracking of murine hematopoietic cells transduced with a bicistronic retrovirus containing CD24 and EGFP genes

K. Ozawa, Y. Ueda, M. Urabe, 2000, Gene Therapy.

Development of a novel selective amplifier gene for controllable expansion of transduced hematopoietic cells.

H. Mano, K. Ozawa, T. Kitamura, 1997, Blood.

Sustained transgene expression by human cord blood derived CD34+ cells transduced with simian immunodeficiency virus agmTYO1‐based vectors carrying the human coagulation factor VIII gene in NOD/SCID mice

A. Ishiwata, S. Madoiwa, J. Mimuro, 2004, The journal of gene medicine.

Sendai virus-mediated expression of reprogramming factors promotes plasticity of human neuroblastoma cells

M. Ohira, A. Nakagawara, Y. Suenaga, 2015, Cancer science.

Anti-tumor angiogenesis effect of aminopeptidase inhibitor bestatin against B16-BL6 melanoma cells orthotopically implanted into syngeneic mice.

Yurika Saitoh, Hiroaki Sakurai, Keiichi Koizumi, 2004, Cancer letters.

TITLE Towards Gene Therapy for Cystic Fibrosis Using a Lentivirus Pseudotyped With Sendai Virus Envelopes

K. Mitomo, Y. Ueda, M. Hasegawa, 2015 .

Pseudotyped Lentivirus Vectors Derived from Simian Immunodeficiency Virus SIVagm with Envelope Glycoproteins from Paramyxovirus

Y. Ueda, M. Hasegawa, A. Iida, 2003, Journal of Virology.

Complete elimination of established neuroblastoma by synergistic action of γ-irradiation and DCs treated with rSeV expressing interferon-β gene

Y. Yonemitsu, K. Sueishi, S. Tanaka, 2009, Gene Therapy.

Efficient gene transfer of a simian immuno‐deficiency viral vector into cardiomyocytes derived from primate embryonic stem cells

U. Ikeda, K. Shimada, K. Ozawa, 2003, The journal of gene medicine.

Synergistic neuroprotective effect via simian lentiviral vector‐mediated simultaneous gene transfer of human pigment epithelium‐derived factor and human fibroblast growth factor‐2 in rodent models of retinitis pigmentosa

S. Tobimatsu, Y. Goto, Y. Yonemitsu, 2008, Journal of Gene Medicine.

Blocking S1P interaction with S1P₁ receptor by a novel competitive S1P₁-selective antagonist inhibits angiogenesis.

Y. Igarashi, Y. Ueda, R. Goitsuka, 2012, Biochemical and biophysical research communications.

VGA1155, a novel binding antagonist of VEGF, inhibits angiogenesis in vitro and in vivo.

T. Yamagishi, S. Nakaike, M. Ono, 2004, Anticancer research.

Simian lentiviral vector-mediated retinal gene transfer of pigment epithelium-derived factor protects retinal degeneration and electrical defect in Royal College of Surgeons rats

S. Tobimatsu, Y. Goto, Y. Yonemitsu, 2003, Gene Therapy.

RIG-I helicase-independent pathway in sendai virus-activated dendritic cells is critical for preventing lung metastasis of AT6.3 prostate cancer.

H. Hayashi, Y. Yonemitsu, Y. Ueda, 2010, Neoplasia.

Cytoplasmic Expression and Extracellular Deposition of an Antiangiogenic Factor, Pigment Epithelium-Derived Factor, in Human Atherosclerotic Plaques

Y. Maehara, I. Yoshino, Y. Yonemitsu, 2005, Arteriosclerosis, thrombosis, and vascular biology.

Non-transmissible Sendai virus vector encoding c-myc suppressor FBP-interacting repressor for cancer therapy.

T. Tomonaga, H. Matsubara, H. Shimada, 2014, World journal of gastroenterology.

Induction of cell fusion/apoptosis in anaplastic thyroid carcinoma in orthotopic mouse model by urokinase‐specific oncolytic Sendai virus

A. Shiotani, Y. Yonemitsu, H. Shimada, 2019, Head & neck.

Development of a modified selective amplifier gene for hematopoietic stem cell gene therapy

K. Matsuda, K. Ozawa, Y. Ueda, 1999, Gene Therapy.

Sendai virus for cancer immunotherapy.

Y. Yonemitsu, Y. Ueda, M. Hasegawa, 2009, Methods in molecular biology.

Expression of human coagulation factor VIII in adipocytes transduced with the simian immunodeficiency virus agmTYO1-based vector for hemophilia A gene therapy

S. Madoiwa, J. Mimuro, Y. Sakata, 2004, Gene Therapy.

Carbon‐ion beam treatment induces systemic antitumor immunity against murine squamous cell carcinoma

Y. Yonemitsu, H. Tsujii, H. Shimada, 2010, Cancer.

Engraftment and tumor formation after allogeneic in utero transplantation of primate embryonic stem cells1

K. Ozawa, K. Takeuchi, N. Ageyama, 2003, Transplantation.

New selective amplifier genes containing c-Mpl for hematopoietic cell expansion.

K. Ozawa, N. Ageyama, K. Terao, 2003, Biochemical and biophysical research communications.

Bi-HAC vector system toward gene and cell therapy.

M. Oshimura, N. Kouprina, V. Larionov, 2014, ACS synthetic biology.

A novel low molecular weight VEGF receptor-binding antagonist, VGA1102, inhibits the function of VEGF and in vivo tumor growth

M. Shibuya, T. Yamagishi, S. Nakaike, 2004, Cancer Chemotherapy and Pharmacology.

Immunostimulatory virotherapy using recombinant Sendai virus as a new cancer therapeutic regimen.

Y. Yonemitsu, Y. Ueda, M. Hasegawa, 2008, Frontiers in bioscience : a journal and virtual library.

Development of immunostimulatory virotherapy using non-transmissible Sendai virus-activated dendritic cells.

Y. Yonemitsu, K. Sueishi, H. Shimada, 2007, Biochemical and biophysical research communications.

Sustained and NK/CD4+ T Cell-Dependent Efficient Prevention of Lung Metastasis Induced by Dendritic Cells Harboring Recombinant Sendai Virus1

Y. Yonemitsu, Y. Ueda, M. Hasegawa, 2009, The Journal of Immunology.

Dendritic Cells Harboring of Lung Metastasis Induced by Cell-Dependent Efficient Prevention T

Y. Ueda, T. Ichikawa, Hiroyoshi Suzuki, 2009 .

Recombinant Sendai Virus Induced by Dendritic Cells Harboring Efficient Prevention of Lung Metastasis T Cell-Dependent + Sustained and NK/CD4

Y. Yonemitsu, Y. Ueda, M. Hasegawa, 2009 .

Expansion of genetically corrected neutrophils in chronic granulomatous disease mice by cotransferring a therapeutic gene and a selective amplifier gene

H. Mizukami, K. Ozawa, H. Moriwaki, 2004, Gene Therapy.

Urokinase-targeted fusion by oncolytic Sendai virus eradicates orthotopic glioblastomas by pronounced synergy with interferon-β gene.

I. Aoki, Y. Yonemitsu, Y. Iwadate, 2010, Molecular therapy : the journal of the American Society of Gene Therapy.

Safe and efficient collection of cytokine-mobilized peripheral blood cells from cynomolgus monkeys (Macaca fascicularis) with human newborn-equivalent body weights.

K. Ozawa, N. Ageyama, F. Ono, 2005, Experimental animals.

Generation of optimized and urokinase-targeted oncolytic Sendai virus vectors applicable for various human malignancies

Y. Yonemitsu, Y. Ueda, M. Hasegawa, 2009, Gene Therapy.

In vivo expansion of gene‐modified hematopoietic cells by a novel selective amplifier gene utilizing the erythropoietin receptor as a molecular switch

K. Ozawa, N. Ageyama, K. Terao, 2004, The journal of gene medicine.

Cotransplantation with MSCs improves engraftment of HSCs after autologous intra-bone marrow transplantation in nonhuman primates.

K. Ozawa, N. Ageyama, Y. Hanazono, 2009, Experimental hematology.

Prevention of immune responses to human erythropoietin in cynomolgus monkeys (Macaca fascicularis).

K. Ozawa, N. Ageyama, F. Ono, 2006, The Journal of veterinary medical science.

Stable retinal gene expression in nonhuman primates via subretinal injection of SIVagm-based lentiviral vectors.

Y. Yonemitsu, K. Sueishi, Y. Murakami, 2009, Human gene therapy.

Sendai virus-mediated gene transfer of the c-myc suppressor far-upstream element-binding protein-interacting repressor suppresses head and neck cancer

A. Shiotani, H. Shimada, K. Matsushita, 2015, Gene Therapy.

Collection and analysis of hematopoietic progenitor cells from cynomolgus macaques (Macaca fascicularis): Assessment of cross‐reacting monoclonal antibodies

K. Ozawa, N. Ageyama, K. Terao, 2003, American journal of primatology.

In vivo selective expansion of gene-modified hematopoietic cells in a nonhuman primate model

K. Ozawa, N. Ageyama, K. Terao, 2002, Gene Therapy.

Introduction of the green fluorescent protein gene into hematopoietic stem cells results in prolonged discrepancy of in vivo transduction levels between bone marrow progenitors and peripheral blood cells in nonhuman primates

K. Ozawa, N. Ageyama, K. Terao, 2002, The journal of gene medicine.

A selective amplifier gene for tamoxifen‐inducible expansion of hematopoietic cells

K. Matsuda, K. Ozawa, I. Kato, 1999, The journal of gene medicine.

Acute toxicity study of a simian immunodeficiency virus-based lentiviral vector for retinal gene transfer in nonhuman primates.

Y. Goto, Y. Yonemitsu, K. Sueishi, 2009, Human gene therapy.

Highly efficient gene transfer into primate embryonic stem cells with a simian lentivirus vector.

K. Ozawa, N. Nakatsuji, Y. Hanazono, 2002, Molecular therapy : the journal of the American Society of Gene Therapy.

Genetic manipulation of primate embryonic and hematopoietic stem cells with simian lentivirus vectors.

K. Ozawa, Y. Hanazono, Y. Ueda, 2003, Trends in cardiovascular medicine.

In vitro transdifferentiation of human peripheral blood mononuclear cells to photoreceptor-like cells

M. Toyoda, Y. Ueda, A. Umezawa, 2016, Biology Open.

A Cytoplasmic RNA Vector Derived from Nontransmissible Sendai Virus with Efficient Gene Transfer and Expression

T. Hirata, Y. Nagai, Y. Ueda, 2000, Journal of Virology.

Sentinel Lymph Node–Targeted Therapy by Oncolytic Sendai Virus Suppresses Micrometastasis of Head and Neck Squamous Cell Carcinoma in an Orthotopic Nude Mouse Model

A. Shiotani, Y. Ueda, M. Tomifuji, 2019, Molecular Cancer Therapeutics.

Toward gene therapy for cystic fibrosis using a lentivirus pseudotyped with Sendai virus envelopes.

Raymond Farley, Uta Griesenbach, Makoto Inoue, 2010, Molecular therapy : the journal of the American Society of Gene Therapy.

Gene Therapy of c-myc Suppressor FUSE-Binding Protein-Interacting Repressor by Sendai Virus Delivery Prevents Tracheal Stenosis

A. Shiotani, H. Shimada, K. Matsushita, 2015, PloS one.

Oncolytic Sendai virus‐induced tumor‐specific immunoresponses suppress “simulated metastasis” of squamous cell carcinoma in an immunocompetent mouse model

A. Shiotani, Y. Ueda, M. Tomifuji, 2019, Head & neck.

Cytokine-based high log-scale expansion of functional human dendritic cells from cord-blood CD34-positive cells

S. Tsujitani, Y. Yonemitsu, Y. Ueda, 2011, Scientific reports.

High-level in vivo gene marking after gene-modified autologous hematopoietic stem cell transplantation without marrow conditioning in nonhuman primates.

M. Taniwaki, K. Ozawa, S. Ikehara, 2004, Molecular therapy : the journal of the American Society of Gene Therapy.

Antitumor effects of synthetic VEGF-receptor binding antagonist, VGA1155.

T. Yamagishi, S. Nakaike, K. Samata, 2005, Anticancer research.

Ex vivo expansion of human HSCs with Sendai virus vector expressing HoxB4 assessed by sheep in utero transplantation.

Y. Hanazono, Y. Ueda, M. Hasegawa, 2011, Experimental hematology.

A novel low molecular weight antagonist of vascular endothelial growth factor receptor binding: VGA1155.

Hajime Takashima, T. Yamagishi, S. Nakaike, 2003, Molecular cancer therapeutics.

A G-CSF receptor-gyrase B fusion gene: A new type of molecular switch for expansion of genetically modified hematopoietic cells.

H. Mano, K. Ozawa, K. Ito, 1999, Biochemical and biophysical research communications.

BioKnife, a Modified Sendai Virus, to Resect Malignant Tumors

Y. Yonemitsu, Y. Ueda, M. Hasegawa, 2013 .

Y. Yonemitsu, Y. Ueda, T. Ichikawa, 2008 .

Efficient and stable Sendai virus-mediated gene transfer into primate embryonic stem cells with pluripotency preserved

K. Ozawa, Y. Hanazono, Y. Ueda, 2005, Gene Therapy.

Novel ALK5 inhibitor TP0427736 reduces TGF-β induced growth inhibition in human outer root sheath cells and elongates anagen phase in mouse hair follicles.

S. Arase, H. Oura, Y. Ueda, 2017 .

Novel ALK5 inhibitor TP0427736 reduces TGF-β induced growth inhibition in human outer root sheath cells and elongates anagen phase in mouse hair follicles

S. Arase, H. Oura, Y. Ueda, 2017, Pharmacological reports : PR.

Cytokine-Based Log-Scale Expansion of Functional Murine Dendritic Cells

Y. Yonemitsu, Y. Ueda, M. Hasegawa, 2009, PloS one.

Simian immunodeficiency virus-based lentivirus vector for retinal gene transfer: a preclinical safety study in adult rats

S. Tobimatsu, Y. Goto, Y. Yonemitsu, 2003, Gene Therapy.